TVTX (STOCKS)
Travere Therapeutics, Inc. Common Stock
$30.220000
-0.100000 (-0.33%)
Prev close: $30.320000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric M. Dube
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,759.37M
- Employees
- 385
- P/E (TTM)
- -27.96
- P/B (TTM)
- 36.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
10
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.28 | $-0.21 | +0.4920 | +232.08% |
|
Jun 2025 (Q2)
|
$-0.14 | $-0.30 | +0.1637 | +53.90% |
|
Mar 2025 (Q1)
|
$-0.47 | $-0.55 | +0.0808 | +14.67% |
|
Dec 2024 (Q4)
|
$-0.73 | $-0.57 | -0.1565 | -27.29% |
Financial Statements
| Assets | $538.58M |
| Current Assets | $371.11M |
| Inventory | $37.55M |
| Other Current Assets | $333.56M |
| Noncurrent Assets | $167.47M |
| Fixed Assets | $4.32M |
| Intangible Assets | $109.44M |
| Other Non-current Assets | $53.72M |
| Liabilities | $465.02M |
| Current Liabilities | $135.07M |
| Accounts Payable | $18.23M |
| Other Current Liabilities | $116.85M |
| Noncurrent Liabilities | $329.94M |
| Equity | $73.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $73.56M |
| Liabilities And Equity | $538.58M |